Alector (ALEC) Competitor Comparison
We are evaluating the key criteria listed to compare Alector (ALEC) against its competitors in the Biotechnology industry.
Market Capitalization
155 / 368Gross Profits
219 / 278Total Revenue
92 / 300EBITDA
252 / 337Free Cashflow
245 / 352Quick Ratio
227 / 357Earnings per Share
188 / 359Dividend yield
0 / 6Total Cash
50 / 358Performance 3 years
228 / 368Performance 5 years
206 / 368Performance 10 years
183 / 368Linearity 3 years
198 / 368Linearity 5 years
110 / 368Linearity 10 years
91 / 368Total Rank
84 / 368Dividend Rank
340 / 368Valuation Rank
179 / 368Piotroski Rank
215 / 368Muliplier Rank
259 / 368Linearity 10 years - ALEC ranking 91 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.